Related Experiment Video
Updated: Mar 9, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Ubiquitin-specific protease 11 (USP11) functions as a tumor suppressor through deubiquitinating and stabilizing VGLL4
Encheng Zhang1, Bing Shen1, Xingyu Mu1
1Department of Urology, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University Shanghai, P. R. China.
Abstract:
VGLL4 is a transcriptional repressor that interacts with transcription factors TEADs and inhibits YAP-induced overgrowth and tumorigenesis. VGLL4 protein was dramatically reduced in various types of human cancers. But how VGLL4 protein is post-transcriptional regulated is poorly understood. In this study, we identify deubiquitinating enzyme USP11 as a novel VGLL4 interactor. We reveal that the USP domain of USP11 and the N-terminal region of VGLL4 are required for mutual binding. USP11 controls VGLL4 protein stability by promoting its deubiquitination. Furthermore, our results show that knockdown of USP11 promotes cell growth, migration, and invasion in a YAP-dependent manner. Together, our results suggest that USP11 may exert its tumor suppressor role by modulating VGLL4/YAP-TEADs regulatory loop.
Insights
The deubiquitinating enzyme USP11 stabilizes VGLL4 protein, a key repressor of cancer growth. USP11
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- VGLL4 (Vestigial-like protein 4) is a transcriptional repressor that inhibits YAP-induced overgrowth and tumorigenesis.
- VGLL4 protein levels are significantly reduced in various human cancers, but its post-transcriptional regulation remains unclear.
- The YAP/TEADs pathway is a critical regulator of cell proliferation and is often dysregulated in cancer.
Purpose of the Study:
- To investigate the post-transcriptional regulation of VGLL4 protein.
- To identify novel interactors and regulators of VGLL4.
- To elucidate the role of USP11 in the VGLL4/YAP-TEADs regulatory loop and its implications in cancer.
Main Methods:
- Co-immunoprecipitation assays to identify VGLL4 interactors.
- Western blotting and ubiquitination assays to assess VGLL4 protein stability.
- Cell proliferation, migration, and invasion assays after USP11 knockdown.
- Analysis of the interaction domains between USP11 and VGLL4.
Main Results:
- Deubiquitinating enzyme USP11 was identified as a novel interactor of VGLL4.
- The USP domain of USP11 and the N-terminal region of VGLL4 are essential for their binding.
- USP11 promotes VGLL4 protein stability by deubiquitination, thereby inhibiting YAP-dependent cell growth, migration, and invasion.
- Knockdown of USP11 leads to increased cell proliferation, migration, and invasion in a YAP-dependent manner.
Conclusions:
- USP11 deubiquitinates and stabilizes VGLL4 protein.
- USP11 acts as a tumor suppressor by modulating the VGLL4/YAP-TEADs regulatory loop.
- USP11 represents a potential therapeutic target for cancers with dysregulated YAP signaling.
Related Concept Videos
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

